The preferable treatment for cirrhotic portal vein thrombosis: anticoagulation or transjugular intrahepatic portosystemic shunt?

Hepatology. 2010 Feb;51(2):713-4. doi: 10.1002/hep.23217.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anticoagulants / therapeutic use*
  • Humans
  • Liver Cirrhosis / complications
  • Portal Vein*
  • Portasystemic Shunt, Transjugular Intrahepatic*
  • Venous Thrombosis / etiology
  • Venous Thrombosis / therapy*

Substances

  • Anticoagulants